Mesothelioma Patients Benefit from Receiving Universal Germl

This new data indicated a necessity for clinical strategies made to handle unintentional pathogenic or likely pathogenic germline variants seen in tumor-only next-generation sequencing.

Related Keywords

Linkedin Michaelw Drazer , Michaelw Drazer , Nat Genet , Laboratory Of University Chicago Genetic Services , Department Of Medicine Section Hematology Oncology , University Of Chicago Medicine , University Of Chicago , Chicago Medicine , Chicago Genetic , Tumor Percentage Score , Variants Incidentally Detected , Tumor Only Genomic Profiling , Patients With , Germline Testing , Mesothilioma ,